Touchstone
Last syncNov 1, 2026, 6:55 PM ET

UTHR

United Therapeutics Corp Health Care Pharmaceutical Preparations Russell 3000
$598.72Close $26.1BMarket cap $437.33 – $598.7252-week range Nov 4, 2026Next report · before the open

Highlights

Strengths

  • Near its high at its 52-week high
  • Volume drying up last 10 days 31% under the 50-day average

Cautions

  • Trend not confirmed 7 of 8 conditions · 50-day under the 150/200-day
  • Extended 4.7 ATR above its 50-day average
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 5, 2026
Off 12-month high 0%
1wk up 1.9% price change
1mo up 10.5% price change
12-month return up 32% market up 11% · its own up 21%
F-score 8 / 9 Exceptional
Altman Z 23.03 Low risk
P/E 19.6× price / earnings
PEG 1.50 P/E / EPS growth
P/B 3.7× price / book
Earnings yield up 6.1% EBIT / enterprise value
Cheaper than 59% of the market · around average
Revenue growth up 11% year on year
EPS growth up 13% latest quarter · +26 pts
Sales growth down 2% latest quarter · -0 pts
ROE up 20% return on equity
Free cash margin up 33% $1.0B FCF
D/E — long-term debt / equity
Net debt / EBITDA -1.0× net cash
Interest cover —EBIT / interest
Piotroski tests
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Trade setup

ATR% 2.9% $17.26 a day · 2×ATR $564.20
RS 76 / 99 vs the universe
Trend 7 / 8 50-day under the 150/200-day
Relative volume 0.7× vs 50-day average
Up/down volume 0.97 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 7 of 8
  • 50-day average above the 150 and 200-day: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Gross margin narrowing Gross margin fell from 89.2% to 87.9%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 5, 2026
Results reaction Aug 5, 2026+3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.2B +11% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.5B FY2021 · $1.7B FY2022 · $1.9B FY2023 · $2.3B FY2024 · $2.9B FY2025 · $3.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $1.3B +12% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · $475.8M FY2022 · $727.3M FY2023 · $984.8M FY2024 · $1.2B FY2025 · $1.3B
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $1.0B -4% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $696.4M FY2021 · $477.4M FY2022 · $663.7M FY2023 · $747.6M FY2024 · $1.1B FY2025 · $1.0B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 88%
  • Net 42%
  • Free cash 33%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 93% · Free cash 47% FY2021 · Gross 93% · Net 28% · Free cash 28% FY2022 · Gross 92% · Net 38% · Free cash 34% FY2023 · Gross 89% · Net 42% · Free cash 32% FY2024 · Gross 89% · Net 42% · Free cash 38% FY2025 · Gross 88% · Net 42% · Free cash 33%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $738.7M FY2021 · Cash $894.8M FY2022 · Cash $961.2M FY2023 · Cash $1.2B FY2024 · Cash $1.7B FY2025 · Cash $1.6B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 43.64m -1.9% since FY2020
47.04m 43.64m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 44.51m FY2021 · 45.11m FY2022 · 46.03m FY2023 · 47.04m FY2024 · 44.83m FY2025 · 43.64m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.5B $1.7B $1.9B $2.3B $2.9B $3.2B
Gross margin 93% 93% 92% 89% 89% 88%
Operating income $593.6M $555.9M $979.7M $1.2B $1.4B $1.5B
Net income — $475.8M $727.3M $984.8M $1.2B $1.3B
Net margin — 28% 38% 42% 42% 42%
Earnings per share — $10.06 $15.00 $19.81 $24.64 $27.86
Free cash flow $696.4M $477.4M $663.7M $747.6M $1.1B $1.0B
Free cash margin 47% 28% 34% 32% 38% 33%
Cash $738.7M $894.8M $961.2M $1.2B $1.7B $1.6B
Shareholders' equity $3.4B $4.0B $4.8B $6.0B $6.4B $7.1B
Shares outstanding 44.51m 45.11m 46.03m 47.04m 44.83m 43.64m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 5, 2026 Quarterly ↗ Jun 30, 2026 36d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 25, 2026 Annual ↗ Dec 31, 2025 56d
Oct 29, 2025 Quarterly ↗ Sep 30, 2025 29d
Jul 30, 2025 Quarterly ↗ Jun 30, 2025 30d
Apr 30, 2025 Quarterly ↗ Mar 31, 2025 30d
Feb 26, 2025 Annual ↗ Dec 31, 2024 57d
Oct 30, 2024 Quarterly ↗ Sep 30, 2024 30d
Jul 31, 2024 Quarterly ↗ Jun 30, 2024 31d
May 1, 2024 Quarterly ↗ Mar 31, 2024 31d
Feb 21, 2024 Annual ↗ Dec 31, 2023 52d
Nov 1, 2023 Quarterly ↗ Sep 30, 2023 32d

Current reports

FiledDisclosed
Oct 22, 2026 Other events ↗
Oct 14, 2026 Other events ↗
Sep 8, 2026 Material agreement · Regulation FD ↗
Aug 5, 2026 Results ↗
Jul 23, 2026 Director or officer change · Regulation FD ↗
Jun 29, 2026 Director or officer change · Shareholder vote ↗
May 6, 2026 Results ↗
Mar 30, 2026 Other events ↗
Mar 9, 2026 Material agreement · Regulation FD ↗
Mar 2, 2026 Regulation FD ↗
Feb 25, 2026 Results ↗
Jan 22, 2026 Director or officer change · Charter or bylaws · Regulation FD ↗